HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kinoshita, K. Articles by Tokunaga, K. Search for Related Content PubMed PubMed Citation Articles by Kinoshita, K. Articles by Tokunaga, K.

The Journal of Thoracic and Cardiovascular Surgery, Vol 101, 695-702, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Superior protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium. Clinical study in comparison with St. Thomas' Hospital solution

K Kinoshita, M Oe and K Tokunaga
Division of Cardiovascular Surgery, Kyushu University, Faculty of Medicine, Fukuoka, Japan.

The protective effect of low-calcium, magnesium-free potassium cardioplegic solution on ischemic myocardium has been assessed in adult patients undergoing heart operations. Postreperfusion recovery of cardiac function and electrical activity was evaluated in 34 patients; 16 received low-calcium, magnesium-free potassium cardioplegic solution (group I) and 18 received St. Thomas' Hospital solution, which is enriched with calcium and magnesium (group II). There were no significant differences between the two groups in age, sex, body weight, and New York Heart Association functional class. Aortic occlusion time (107.3 +/- 46.8 minutes versus 113.6 +/- 44.3 minutes), highest myocardial temperature during elective global ischemia (11.5 degrees C +/- 3.1 degrees C versus 9.3 degrees C +/- 3.2 degrees C), and total volume of cardioplegic solution (44.2 +/- 20.5 ml/kg versus 43.4 +/- 17.6 ml/kg) were also similar in the two groups. On reperfusion, electrical defibrillation was required in four cases (25.5%) in group I and in 15 cases (83.3%) in group II (p less than 0.005), and bradyarrhythmias were significantly more prevalent in group II (6.3% versus 44.4%; p less than 0.05). Serum creatine kinase MB activity at 15 minutes of reperfusion (12.3 +/- 17.0 IU/L versus 42.6 +/- 46.1 IU/L; p less than 0.05) and the dose of dopamine or dobutamine required during the early phase of reperfusion (1.8 +/- 2.5 micrograms/kg/min versus 6.1 +/- 3.3 micrograms/kg/min; p less than 0.0002) were both significantly greater in group II. Postischemic left ventricular function, as assessed by percent recovery of the left ventricular end-systolic pressure-volume relationship in patients who underwent aortic valve replacement alone, was significantly better in group I (160.4% +/- 45.5% versus 47.8% +/- 12.9%; p less than 0.05). Serum level of calcium and magnesium ions was significantly lower in group I. Thus low-calcium, magnesium-free potassium cardioplegic solution provided excellent protection of the ischemic heart, whereas St. Thomas' Hospital solution with calcium and magnesium enabled relatively poor functional and electrical recovery of the heart during the early reperfusion period. These results might be related to differing levels of extracellular calcium and magnesium on reperfusion.

This article has been cited by other articles:

				Y. Tanoue, H. Kado, Y. Shiokawa, N. Fusazaki, and S. Ishikawa Midterm Ventricular Performance After Norwood Procedure With Right Ventricular-Pulmonary Artery Conduit Ann. Thorac. Surg., December 1, 2004; 78(6): 1965 - 1971. [Abstract] [Full Text] [PDF]

				Y. Tanoue, H. Kado, T. Maeda, Y. Shiokawa, N. Fusazaki, and S. Ishikawa Left ventricular performance of pulmonary atresia with intact ventricular septum after right heart bypass surgery J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 710 - 717. [Abstract] [Full Text] [PDF]

				Y. Tomita, H. Yasui, T. Iwai, T. Nishida, S. Morita, M. Masuda, T. Sano, Y. Nishimura, and H. Tatewaki Extensive use of polytetrafluoroethylene artificial grafts for prolapse of posterior mitral leaflet Ann. Thorac. Surg., September 1, 2004; 78(3): 815 - 819. [Abstract] [Full Text] [PDF]

				Y. Tanoue, H. Kado, and Y. Shiokawa Uhl's anomaly complicated with critical ventricular arrhythmia in a 2-month-old infant Eur J Cardiothorac Surg, December 1, 2003; 24(6): 1040 - 1042. [Abstract] [Full Text] [PDF]

				Y. Tanoue, A. Sese, Y. Imoto, and K. Joh Ventricular mechanics in the bidirectional glenn procedure and total cavopulmonary connection Ann. Thorac. Surg., August 1, 2003; 76(2): 562 - 566. [Abstract] [Full Text] [PDF]

				Y. Tanoue, A. Sese, Y. Ueno, K. Joh, and T. Hijii Bidirectional Glenn Procedure Improves the Mechanical Efficiency of a Total Cavopulmonary Connection in High-Risk Fontan Candidates Circulation, May 1, 2001; 103(17): 2176 - 2180. [Abstract] [Full Text] [PDF]

				Y. Tanoue, R. Tominaga, Y. Ochiai, K. Fukae, S. Morita, Y. Kawachi, and H. Yasui Comparative study of retrograde and selective cerebral perfusion with transcranial Doppler Ann. Thorac. Surg., March 1, 1999; 67(3): 672 - 675. [Abstract] [Full Text] [PDF]

				H. Mayumi, Q.-W. Zhang, A. Nakashima, M. Masuda, H. Kohno, Y. Kawachi, and H. Yasui Synergistic Immunosuppression Caused by High-Dose Methylprednisolone and Cardiopulmonary Bypass Ann. Thorac. Surg., January 1, 1997; 63(1): 129 - 137. [Abstract] [Full Text]

				Y. Tanoue, S. Morita, Y. Ochiai, M. Hisahara, M. Masuda, Y. Kawachi, R. Tominaga, and H. Yasui INHIBITION OF LIPID PEROXIDATION WITH THE LAZAROID U74500A ATTENUATES ISCHEMIA-REPERFUSION INJURY IN A CANINE ORTHOTOPIC HEART TRANSPLANTATION MODEL J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1017 - 1026. [Abstract] [Full Text]

				M. Oe, T. Asou, S. Morita, H. Yasui, and K. Tokunaga PROTAMINE-INDUCED HYPOTENSION IN HEART OPERATIONS: APPLICATION OF THE CONCEPT OF VENTRICULAR-ARTERIAL COUPLING J. Thorac. Cardiovasc. Surg., August 1, 1996; 112(2): 462 - 471. [Abstract] [Full Text]

				J. C. Stringham, K. L. Paulsen, J. H. Southard, R. M. Mentzer Jr., and F. O. Belzer Prolonging myocardial preservation with a modified University of Wisconsin solution containing 2,3-butanedione monoxime and calcium J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 764 - 775. [Abstract] [Full Text]

				N. Takemoto, H. Kuroda, T. Hamasaki, Y. Hara, S. Ishiguro, and T. Mori Effect of magnesium and calcium on myocafdial protection by cardioplegic solutions Ann. Thorac. Surg., January 1, 1994; 57(1): 177 - 182. [Abstract] [PDF]

				K. Kinoshita, A. Mitani, Y. Tsuruhara, Y. Kanegae, and K. Tokunaga Analysis of determinants of ventricular fibrillation induced by reperfusion: Dissociation between electrical instability and myocardial damage Ann. Thorac. Surg., June 1, 1992; 53(6): 999 - 1005. [Abstract] [PDF]